PURA and USMJ Announce EVERx CBD Infused Gummies Launch In Conjunction With Annual 420 Celebration Next Week
April 11 2017 - 8:49AM
InvestorsHub NewsWire
Dallas, TX -- April 11,
2017 -- InvestorsHub NewsWire -- Puration, Inc. (USTOC:
PURA) and North American Cannabis Holdings, Inc.
(USOTC:
USMJ) more commonly known as “USMJ,”
today announced the launch of a CBD infused sports nutrition
supplement gummy under the EVERx brand name. The EVERx CBD
Infused Gummies for Post Workout Recovery will be available for the
first time at USMJ’s AmeriCanna Cafe display at the upcoming
Southwest Cannabis Conference and
Expo In Fort Worth, Texas April 22-23. An online
presentation of the new EVERx CBD Infused Gummies for Post Workout
Recovery will be published Thursday, April 13, 2017.
The EVERx Brand is owned by USMJ. PURA has licensed the
production of select products under the EVERx Brand. PURA has licensed a U.S. Patented
process for cannabis extraction and has entered into a number
of agreements to infuse its proprietary CBD extract into food and
beverage products. PURA recently introduce EVERx CBD Infused
Bottled Sports Water and EVERx Alkaline Bottled Sports Water at
Arnold Schwarzenegger’s Annual Arnold Sports
Festival. EVERx CBD Infused Bottles Sports Water and
EVERx Alkaline Bottled Sports Water will both be avaialbe along
with the new EVERx CBD Infused Gummies For Post Workout Recovery at
the upcoming Southwest Cannabis Conference and Expo in Fort Worth,
Texas April 22-23.
The EVERx CBD Infused Bottled Sports Water and the EVERx CBD
Alakaline Bottled Sports water are both bottled by Alkame Holdings,
Inc. (USOTC:
ALKM) and both include the ALKM's US Patented water
molecule.
Learn More About
USMJ:
growusmj.com
Learn More About
PURA:
purationinc.com
Learn More About ALKM:
alkamewater.com
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the
meaning of the Securities Litigation Reform Act. The statements
reflect the Company's current views with respect to future events
that involve risks and uncertainties. Among others, these risks
include the expectation that any of the companies mentioned herein
will achieve significant sales, the failure to meet schedule or
performance requirements of the companies’ contracts, the
companies’ liquidity position, the companies’ ability to obtain new
contracts, the emergence of competitors with greater financial
resources and the impact of competitive pricing. In the light of
these uncertainties, the forward-looking events referred to in this
release might not occur. These statements have not been evaluated
by the Food and Drug Administration. These products are not
intended to diagnose, treat, cure or prevent any disease.
Puration Contact:
Brian Shibley, CEO
info@purationinc.com
+1-214-937-9097
North American Cannabis Holdings Contact:
Steven Rash
Phone: +1-972-528-0162
Email: Info@growusmj.com
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Apr 2023 to Apr 2024